Cumberland Pharmaceuticals Inc (NAS:CPIX) Stock News, Headlines & Updates
Cumberland Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jun 23, 2025
Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
PRNewswire • 9:00am
Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference | CPIX Stock News
GuruFocus News • 8:16am
May 27, 2025
NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS
PRNewswire • 4:00pm
NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS | CPIX Stock News
GuruFocus News • 3:15pm
May 13, 2025
CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH
PRNewswire • 4:00pm
CPIX Partners with Qureight for Enhanced IPF Trial Insights | CPIX Stock News
GuruFocus News • 3:47pm
CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH | CPIX Stock News
GuruFocus News • 3:18pm
May 07, 2025
Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Market Expansions
GuruFocus News • 1:20am
Q1 2025 Cumberland Pharmaceuticals Inc Earnings Call Transcript
GuruFocus News • 11:08pm
May 06, 2025
Cumberland Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS at $0.16, Revenue Hits $11.7 Million
GuruFocus News • 4:33pm
Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025
PRNewswire • 4:00pm
Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 | CPIX Stock News
GuruFocus News • 3:20pm
Apr 29, 2025
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE
PRNewswire • 4:00pm
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE | CPIX Stock News
GuruFocus News • 3:19pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news